Fund profile / United States

Curie.Bio (II)

Geography: United States
Stage: Seed
Fund size: $340M
Focus: Deep Tech and SaaS
Signals: Published

N°01 / About

About Curie.Bio (II)

Curie.Bio (II) is a venture capital firm based in United States, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

N°02 / Thesis

Investment Focus

Location / RegionUnited States

Funding StageSeed

Industry Focus

Deep Tech

SaaS

Investor Signals Profile

active

Sweet Spot

Biotech founders: biologics/small molecules, translational ready, oncology/immunology

biotech

biologics

drug discovery

clinical translation

small molecules

oncology

European expansion

Bullish Signals

Operator CXOs embedded with foundersexternal

RNA therapeutics across multiple modalitiesexternal

CXO guides discovery through clinical stagelinkedin

29K+ LinkedIn followers — strong portfolio visibilitylinkedin

Genentech + Synthekine scaling experience embeddedlinkedin

Blueprint Medicines FDA approval — world-class drug hunterslinkedin

Prana Therapies Phase 1 positive: rapid, durable PD activitylinkedin

INSPIRE platform validates bispecific antibody differentiationlinkedin

PRA-216: 85% subcutaneous bioavailability, 12-week dosinglinkedin

Portfolio de-risking: clinical data expected 2027linkedin

European ambassador: 25yr pharma discovery translation expertiselinkedin

Brigimadlin lead: target validation to clinic credibilitylinkedin

Research Beyond Borders: early modality adoption track recordlinkedin

Contrarian Signals

Highly specialized — narrow biotech focusexternal

Founder Do's

Bring deep scientific domain expertise

Focus on translational development readiness

Engage with CXO network early

Leverage operator GPs for company building + science

Tap program development discovery-to-clinic

Design differentiated modalities (bispecific, multispecific, extended half-life)

Target patient convenience — at-home dosing potential

Pressure-test hypothesis before scaling

Founder Don'ts

Skip clinical positioning strategy

Underestimate biologics modality complexity

Bypass GP involvement in early discovery

34 signals on Curie.Bio (II)

13 bullish · 1 contrarian · 8 pitch do's · 3 don'ts · 9 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size$340M

Saves0

Website

People

Key People

Zach Weinberg, Alexis Borisy

Aimee JacksonCXO

Patrick LupardusPartner

Alexis BorisyPartner

Christoph LengauerPartner

Timothy GuziAdvisor/Team

Erica EvansAdvisor/Team

Sheila GujrathiPortfolio Founder

Miguel SanjuanPortfolio Founder

Guido BoehmeltAmbassador/Advisor

N°04 / See also

Related Funds

Levine Leichtman Capital Partners Fund VII

Fund size$3.6B

Location: United States
Stage: Late Stage
Focus: Ai Ml, Digital Education Consumer, Deep Tech
Manager: Matthew Frankel, Michael Weinberg

Late Stage

Ai Ml

Digital Education Consumer

Deep Tech

Boardy Ventures Fund I

Location: United States
Stage: Pre Seed
Focus

Pre Seed

Warburg Pincus Capital Solutions Founders Fund

Fund size$4000M

Location: United States
Stage: Late Stage
Focus: Climate Sustainability, Ecommerce, Saas
Manager: Jeffrey Erlman

Late Stage

Climate Sustainability

Ecommerce

Saas